Improving the Detection of Active Tuberculosis in Accident and Emergency Departments
NCT ID: NCT02512484
Last Updated: 2016-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1000 participants
OBSERVATIONAL
2016-05-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing for Tuberculosis in the United Kingdom HIV Infected Population
NCT02712671
Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control Program
NCT02174380
Point-of-care Triage Test for Active Tuberculosis
NCT04232618
Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?
NCT00214708
Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT
NCT03220464
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A\&E Departments are an important point of testing and referral for the client group that constitute those at greatest risk, as for many this will be their only interaction with the health service. Currently, A\&E Departments contribute about 20% of those diagnosed with TB. The majority of these individuals are most likely to have presented with symptoms indicative of disease, compared to those attending for other reasons who would have been unlikely to have been tested or referred.
This study will seek to evaluate specific measures currently being undertaken by Public Health England and the NHS to control TB as well as investigate whether case finding for active TB in A\&E departments would improve TB control. The economic impact of these interventions will be evaluated, providing a measure of its value for money.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
high risk TB individuals attending A&E Departments
Assessment against inclusion/exclusion criteria in terms of risk of TB. If eligible, assessment and testing as appropriate for active or latent TB
venepuncture, sputum collection, xray
venepuncture, sputum collection, xray
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
venepuncture, sputum collection, xray
venepuncture, sputum collection, xray
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Those with social risk factors who have signs and/or symptoms of TB.
Exclusion Criteria
2. Individuals who were born in the UK or a low incidence countries and do not have risk factors
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Public Health England
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jo Southern
Clinical Research Lead
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barts NHS Trust
London, London, United Kingdom
Ealing Hospital
London, London, United Kingdom
West Middlesex Hospital NHS Trust
London, London, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Gupta RK, Lule SA, Krutikov M, Gosce L, Green N, Southern J, Imran A, Aldridge RW, Kunst H, Lipman M, Lynn W, Burgess H, Rahman A, Menezes D, Rahman A, Tiberi S, White PJ, Abubakar I. Screening for tuberculosis among high-risk groups attending London emergency departments: a prospective observational study. Eur Respir J. 2021 Jun 24;57(6):2003831. doi: 10.1183/13993003.03831-2020. Print 2021 Jun.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TB A&E study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.